Rapid Spread in Japan of Unusual G9P[8] Human Rotavirus Strains Possessing NSP4 Genes of E2 Genotype.


Journal

Japanese journal of infectious diseases
ISSN: 1884-2836
Titre abrégé: Jpn J Infect Dis
Pays: Japan
ID NLM: 100893704

Informations de publication

Date de publication:
22 Sep 2022
Historique:
pubmed: 2 5 2022
medline: 24 9 2022
entrez: 1 5 2022
Statut: ppublish

Résumé

The emergence of unusual G9P[8]-E2 human rotaviruses in the Tokyo metropolitan area, Japan, in 2018 has been reported. During rotavirus strain surveillance in different regions of Japan (Mie, Okayama, and Chiba prefectures), G9P[8]-E2 strains were detected in children with diarrhea from all three prefectures. Here, we characterized the whole genome of seven representative G9P[8]-E2 strains. In the full-genome-based analysis, the seven study strains exhibited a unique genotype configuration with the NSP4 gene of genogroup 2 in a genogroup 1 genomic backbone: G9-P[8]-I1-R1-C1-M1-A1-N1-T1-E2-H1. This genotype constellation was shared by the Tokyo G9P[8]-E2 strains. Phylogenetic analysis showed that all 11 genes, except NSP4, of the seven study strains appeared to have originated from co-circulating Wa-like G9P[8]-E1 strains. In contrast, NSP4 appeared to have originated from the co-circulating DS-1-like G2P[4]-E2 strains. Thus, G9P[8]-E2 strains appear to be derived through reassortment between G9P[8]-E1 and G2P[4]-E2 strains in Japan. Notably, the seven study G9P[8]-E2 strains and Tokyo G9P[8]-E2 strains were revealed to have 11-segment genomes almost indistinguishable from one another in their sequences (99.3-100%), indicating all these G9P[8]-E2 strains had a common origin. To our knowledge, this is the first description of the rapid spread of G9P[8]-E2 strains across a country.

Identifiants

pubmed: 35491229
doi: 10.7883/yoken.JJID.2022.020
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

466-475

Auteurs

Saori Fukuda (S)

Department of Virology and Parasitology, Fujita Health University School of Medicine, Japan.

Yuki Akari (Y)

Department of Virology and Parasitology, Fujita Health University School of Medicine, Japan.

Riona Hatazawa (R)

Department of Virology and Parasitology, Fujita Health University School of Medicine, Japan.

Manami Negoro (M)

Institute for Clinical Research, National Mie Hospital, Japan.

Takaaki Tanaka (T)

Department of Pediatrics, Kawasaki Medical School, Japan.

Kazutoyo Asada (K)

Department of Pediatrics, National Mie Hospital, Japan.

Haruna Nakamura (H)

Department of Pediatrics, National Mie Hospital, Japan.

Katsumi Sugiura (K)

Department of Pediatrics, National Mie Hospital, Japan.

Masakazu Umemoto (M)

Umemoto Children's Clinic, Japan.

Haruo Kuroki (H)

Sotobo Children's Clinic, Japan.

Hiroaki Ito (H)

Department of Pediatrics, Kameda Medical Center, Japan.

Shigeki Tanaka (S)

Department of Pediatrics, Mie Chuo Medical Center, Japan.

Mitsue Ito (M)

Department of Pediatrics, Japanese Red Cross Ise Hospital, Japan.

Tomihiko Ide (T)

Department of Virology and Parasitology, Fujita Health University School of Medicine, Japan.

Takayuki Murata (T)

Department of Virology and Parasitology, Fujita Health University School of Medicine, Japan.

Kiyosu Taniguchi (K)

Department of Pediatrics, National Mie Hospital, Japan.

Shigeru Suga (S)

Department of Pediatrics, National Mie Hospital, Japan.

Hajime Kamiya (H)

Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan.

Takashi Nakano (T)

Department of Pediatrics, Kawasaki Medical School, Japan.

Koki Taniguchi (K)

Department of Virology and Parasitology, Fujita Health University School of Medicine, Japan.

Satoshi Komoto (S)

Department of Virology and Parasitology, Fujita Health University School of Medicine, Japan.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH